10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| TXG | 10x Genomics, Inc. | 2026-03-03 12:08:01 | 22.11 | -1.03 | -4.45 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TXG | 0001770787 | 10x Genomics, Inc. | US88025U1097 | 5493003Z6741WNLG7H43 | 455614458 | Nasdaq | 3826 | Laboratory Analytical Instruments | 1231 | DE | 6230 STONERIDGE MALL ROAD | PLEASANTON | CA | 94588 | UNITED STATES | US | (925) 401-7300 | 6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588 | 6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588 | — | — | 2012 | Serge Saxonov | 1,306 | http://10xgenomics.com | 1,300,000,000 | 127,691,329 | — | 10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics. | 2026-02-26 17:16:25 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 1,300,000,000 | -500,000,000 | -27.7778 | — | — | — |
| 2024 | 1,800,000,000 | -3,900,000,000 | -68.4211 | — | — | — |
| 2023 | 5,700,000,000 | 1,200,000,000 | 26.6667 | — | — | — |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Benjamin J. Hindson | Chief Scientific Officer, President | 2024 | 485,250 | 0 | 3,634,816 | 150,000 | 0 | 4,270,066 |
| Eric S. Whitaker | Chief Legal Officer | 2024 | 484,725 | 0 | 6,360,897 | 150,000 | 0 | 6,995,622 |
| Serge Saxonov | Chief Executive Officer | 2024 | 625,312 | 0 | 6,979,037 | 325,000 | 0 | 7,929,349 |
| Adam S. Taich | Chief Financial Officer | 2024 | 192,308 | 0 | 3,045,730 | 58,197 | 0 | 3,296,235 |
| Justin J. Mcanear | Chief Financial Officer | 2024 | 311,795 | 0 | 2,726,082 | 0 | 0 | 3,037,877 |
| Fiscal Year | Employee Count |
|---|---|
| 2025 | 1,178 |
| 2024 | 1,306 |
| 2023 | 1,259 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 642,823,000 | 610,785,000 | 618,727,000 |
| Cost Of Revenue | 198,942,000 | 196,303,000 | 209,414,000 |
| Gross Profit | 443,881,000 | 414,482,000 | 409,313,000 |
| Research And Development Expenses | 238,632,000 | 264,698,000 | 270,332,000 |
| General And Administrative Expenses | 316,134,000 | 344,343,000 | 343,330,000 |
| Operating Expenses | 504,866,000 | 609,041,000 | 674,642,000 |
| Operating Income | -60,985,000 | -194,559,000 | -265,329,000 |
| Net Income | -43,544,000 | -182,627,000 | -255,099,000 |
| Earnings Per Share Basic | -0.35 | -1.52 | -2.18 |
| Earnings Per Share Diluted | -0.35 | -1.52 | -2.18 |
| Weighted Average Shares Outstanding Basic | 124,749,885 | 120,451,550 | 117,165,036 |
| Weighted Average Shares Outstanding Diluted | 124,749,885 | 120,451,550 | 117,165,036 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 473,966,000 | 344,067,000 | 359,284,000 |
| Marketable Securities Current | 49,443,000 | 49,335,000 | 29,411,000 |
| Accounts Receivable | 47,013,000 | 87,862,000 | 114,832,000 |
| Inventories | 56,341,000 | 83,107,000 | 73,706,000 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | — | — | — |
| Total Assets Current | 684,451,000 | 584,387,000 | 596,022,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 226,711,000 | 252,648,000 | 279,571,000 |
| Other Assets Non Current | 2,913,000 | 4,129,000 | 3,062,000 |
| Total Assets Non Current | 356,914,000 | 334,249,000 | 369,121,000 |
| Total Assets | 1,041,365,000 | 918,636,000 | 965,143,000 |
| Accounts Payable | 12,733,000 | 12,909,000 | 15,738,000 |
| Deferred Revenue | 23,902,000 | 20,658,000 | 13,150,000 |
| Short Term Debt | — | — | — |
| Other Liabilities Current | 10,871,000 | 8,513,000 | 4,413,000 |
| Total Liabilities Current | 153,454,000 | 117,633,000 | 127,162,000 |
| Long Term Debt | — | — | — |
| Other Liabilities Non Current | 6,471,000 | 5,029,000 | 4,275,000 |
| Total Liabilities Non Current | 91,585,000 | 90,869,000 | 96,938,000 |
| Total Liabilities | 245,039,000 | 208,502,000 | 224,100,000 |
| Common Stock | 2,000 | 2,000 | 2,000 |
| Retained Earnings | -1,510,591,000 | -1,467,047,000 | -1,284,420,000 |
| Accumulated Other Comprehensive Income | 225,000 | -493,000 | -429,000 |
| Total Shareholders Equity | 796,326,000 | 710,134,000 | 741,043,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 36,199,000 | 35,879,000 | 35,512,000 |
| Share Based Compensation Expense | 109,118,000 | 140,749,000 | 166,950,000 |
| Other Non Cash Income Expense | — | — | — |
| Change In Accounts Receivable | -41,314,000 | -26,951,000 | 10,613,000 |
| Change In Inventories | -27,953,000 | 9,777,000 | -7,871,000 |
| Change In Non Trade Receivables | 34,874,000 | — | — |
| Change In Other Assets | -689,000 | 1,084,000 | 678,000 |
| Change In Accounts Payable | -2,126,000 | -3,354,000 | -6,017,000 |
| Change In Other Liabilities | — | — | — |
| Cash From Operating Activities | 136,050,000 | 6,664,000 | -15,197,000 |
| Purchases Of Marketable Securities | 123,435,000 | 48,876,000 | 0 |
| Sales Of Marketable Securities | 125,200,000 | 25,782,000 | 82,825,000 |
| Acquisition Of Property Plant And Equipment | 5,935,000 | 12,393,000 | 48,601,000 |
| Acquisition Of Business | — | 0 | 0 |
| Other Investing Activities | — | — | — |
| Cash From Investing Activities | -13,438,000 | -32,631,000 | 133,492,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | — | — | — |
| Issuance Of Long Term Debt | — | — | — |
| Repayment Of Long Term Debt | — | — | — |
| Other Financing Activities | 6,803,000 | 10,914,000 | 19,483,000 |
| Cash From Financing Activities | 6,803,000 | 10,914,000 | 13,669,000 |
| Change In Cash | 129,899,000 | -15,217,000 | 131,931,000 |
| Cash At End Of Period | 473,966,000 | 344,067,000 | 359,284,000 |
| Income Taxes Paid | 2,391,000 | 5,641,000 | 4,927,000 |
| Interest Paid | 0 | 0 | 436,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | -0.35 | -1.52 | -2.18 |
| Price To Earnings Ratio | -46.6 | -9.4474 | -25.6697 |
| Earnings Growth Rate | -76.9737 | -30.2752 | 49.3151 |
| Price Earnings To Growth Ratio | 0.6054 | 0.312 | -0.5205 |
| Book Value Per Share | 6.3834 | 5.8956 | 6.3248 |
| Price To Book Ratio | 2.5551 | 2.4357 | 8.8477 |
| Ebitda | -4,954,000 | -141,103,000 | -214,627,000 |
| Enterprise Value | — | — | — |
| Dividend Yield | — | — | — |
| Dividend Payout Ratio | — | — | — |
| Debt To Equity Ratio | — | — | — |
| Capital Expenditures | 10,262,000 | 8,956,000 | 25,755,000 |
| Free Cash Flow | 125,788,000 | -2,292,000 | -40,952,000 |
| Return On Equity | -0.0547 | -0.2572 | -0.3442 |
| One Year Beta | 1.9156 | 2.0248 | 1.9372 |
| Three Year Beta | 1.9408 | 2.1881 | 2.0974 |
| Five Year Beta | 2.0382 | 1.3365 | 1.2793 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Taich Adam | Chief Financial Officer | 2026-02-26 | 106,579 | A | 394,996 |
| Hindson Benjamin J. | Director | 2026-02-26 | 88,816 | A | 513,595 |
| Saxonov Serge | Director, Chief Executive Officer | 2026-02-26 | 157,895 | A | 1,219,819 |
| Teichmann Sarah A. | Director | 2026-02-25 | 7,579 | D | 26,780 |
| Hindson Benjamin J. | Director | 2026-02-23 | 7,826 | D | 424,779 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| Caitong International Asset Management Co., Ltd | 2025-12-31 | 14,402 | 883 | 16.3103 |
| Bell Investment Advisors, Inc | 2025-12-31 | 995 | 61 | 16.3115 |
| Kera Capital Partners, Inc. | 2025-12-31 | 966,146 | 47,829 | 20.2 |
| MV CAPITAL MANAGEMENT, INC. | 2025-12-31 | 5,693 | 349 | 16.3123 |
| Sunbelt Securities, Inc. | 2025-12-31 | 2,479 | 152 | 16.3092 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| RYDEX SERIES FUNDS | 2025-12-31 | Class C | RYCMX | 147 | 2,397.57 | 0.0284 |
| RYDEX SERIES FUNDS | 2025-12-31 | Class A | RYAKX | 147 | 2,397.57 | 0.0284 |
| RYDEX SERIES FUNDS | 2025-12-31 | Class H | RYMKX | 147 | 2,397.57 | 0.0284 |
| RYDEX DYNAMIC FUNDS | 2025-12-31 | H-Class Shares | RYRSX | 538 | 8,774.78 | 0.0161 |
| RYDEX DYNAMIC FUNDS | 2025-12-31 | C-Class Shares | RYRLX | 538 | 8,774.78 | 0.0161 |